Market Cap

Protalix BioTherapeutics, Inc. Market Capitalization:

₪292.9 Million

ILS as of Jan. 1, 2023

US$83.6 Million

business Protalix BioTherapeutics, Inc. Company Profile

Protalix BioTherapeutics, Inc. Main Stock Listing

TASE: PLX

Market Capitalization History of Protalix BioTherapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Protalix BioTherapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 ₪292.9 M 119.45%
Jan. 1, 2022 ₪133.5 M -81.33%
Jan. 1, 2021 ₪715.1 M 15.95%
Jan. 1, 2020 ₪616.7 M -25.12%
Jan. 1, 2019 ₪823.7 M -31.74%
Jan. 1, 2018 ₪1.21 B 2.45%
Jan. 1, 2017 ₪1.18 B -30.83%
Jan. 1, 2016 ₪1.70 B -58.30%
Jan. 1, 2015 ₪4.08 B -45.38%
Jan. 1, 2014 ₪7.48 B -22.13%
Jan. 1, 2013 ₪9.60 B -6.38%
Jan. 1, 2012 ₪10.26 B -94.12%
Jan. 1, 2011 ₪174.37 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Protalix BioTherapeutics, Inc. has the following listings and related stock indices.


Stock: TASE: PLX

Stock: NYSE: PLX

Stock: FSX: PBDA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.